ArticleTrials2018

High-flow nasal oxygen vs. standard oxygen therapy in immunocompromised patients with acute respiratory failure: study protocol for a randomized controlled trial.

Elie Azoulay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.